In the RPTEC-TERT1, CAKI-1, and HRPTECs, the P-gp expression was upregulated after treatment with CTX, which indicated that the upstream regulatory pathways governed by EGFR can dictate P-gp expression in both RCC and healthy renal RPTECs. The gene discussed is EGFR; the disease is renal cell carcinoma.